About Actgen Pharma Private Limited
Data last updated:
Actgen Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 08 March 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2008PTC179859. Its GSTIN is 24AAGCA8549K1ZB (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹9 Cr and a paid-up capital of ₹9 Cr. It is led by directors Kantilal Mangalchand Hiran and Dariyadevi Kantilal Hiran.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 45 1st Floor Rustomjee Ease Zone Goregaon Mulund Link Road Malad (West), Mumbai, Maharashtra, India – 400062.
As per the financials filed for FY 2023, the company reported a revenue of ₹10.17 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹9.86 Cr (net margin 96.9%) and EBITDA of ₹9.86 Cr (EBITDA margin 96.9%). Revenue has grown at a compounded annual rate (CAGR) of 70% over three years.
The company is associated with 1 brand: ActGen Pharma. As per MCA filings, the company has satisfied charges of ₹72 Cr on record. Court records list 20 cases involving the company, including 9 filed by the company and 11 filed against it.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website actgen.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressShop No. 45 1st Floor Rustomjee Ease Zone Goregaon Mulund Link Road Malad (West), Mumbai, Maharashtra, India – 400062
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Actgen Pharma Private Limited FY 2025 filings available
Actgen Pharma Private Limited reported revenue of ₹10.17 Cr (up 980% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Actgen Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 70% over three years, including 980% growth in the latest year. EBITDA rose 958% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Actgen Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹10.17 Cr | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹9.86 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹9.86 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Actgen Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 96.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 96.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Actgen Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Actgen Pharma Private Limited
Actgen Pharma Private Limited is audited by RDJ and Associates LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RDJ and Associates LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Actgen Pharma Private Limited
Actgen Pharma has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kantilal Mangalchand Hiran Also directs: Sunflower Trading and Investment Pvt Ltd | Director | 05 Sep 2023 | 3 Years 1 Months | Current |
| Dariyadevi Kantilal Hiran | Director | 06 Nov 2023 | 2 Years 11 Months | Current |
Ownership and Shareholding of Actgen Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Actgen Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jan 2010 | Bank of India | ₹27 Cr | Satisfied |
| 27 Feb 2009 | Bank of India | ₹27 Cr | Satisfied |
| 27 Nov 2008 | Bank of India | ₹18 Cr | Satisfied |
Total charge records: 3 View all charges
Legal Cases of Actgen Pharma Private Limited
Actgen Pharma Private Limited has 20 court cases on record: 9 filed by Actgen Pharma, 11 filed against it. All cases are disposed. Status as checked between 21 Sep 2026 and 05 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 10 | 0 |
| High courts | 8 | 1 | 0 |
| Supreme Court | 2 | 0 | 0 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed by the company against Sicom Limited | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by Checkmate Services Private Limited | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Ss case SS) | Filed against the company by Khushbu Dye-Chem Private Limited | Disposed |
| High Court of Gujarat | Court case (TAXAP) | Filed by the company against State of Gujarat | Disposed |
| District court, Bharuch, Gujarat | Court case (EXE S) | Filed against the company by Kirjitsinh Kiranbhai Patel P/O Parth Construction | Disposed |
Full case history
All 20 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Actgen Pharma Private Limited
Actgen Pharma operates one associated brand: ActGen Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures active pharmaceutical ingredients (APIs). | actgen.in |
Employees and EPFO Compliance at Actgen Pharma Private Limited
Actgen Pharma Private Limited has a workforce of 0 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Actgen Pharma Private Limited
Actgen Pharma Private Limited has 10 board changes on record since 2019: 2 appointments and 8 cessations. The latest: Yogesh Uttamchand Hiran ceased to be Director on 16 Nov 2023.
8 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Actgen Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Actgen Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Actgen Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Actgen Pharma Private Limited
Actgen Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAGCA8549K1ZB | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Actgen Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Actgen Pharma Private Limited
Actgen Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 08 March 2008 (18+ years old) and is registered under CIN U24239MH2008PTC179859.
Actgen Pharma reported revenue of ₹10.17 Cr for FY 2023 (up 980% YoY).
Actgen Pharma has 2 current directors:
- Kantilal Mangalchand Hiran - Director
- Dariyadevi Kantilal Hiran - Director
Actgen Pharma reported a net profit of ₹9.86 Cr (net margin 96.9%) and EBITDA of ₹9.86 Cr (EBITDA margin 96.9%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Actgen Pharma is 70% over three years. In the latest year (FY 2023) revenue rose 980%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Actgen Pharma is 24AAGCA8549K1ZB, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Actgen Pharma is U24239MH2008PTC179859. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Actgen Pharma has 20 court cases on record: 9 filed by the company and 11 filed against it. Most are in the district courts.
Actgen Pharma was incorporated on 08 March 2008, making it 18+ years old. It is registered with the Registrar of Companies, Mumbai.
Yogesh Uttamchand Hiran ceased to be Director on 16 Nov 2023. Dariyadevi Kantilal Hiran was appointed as Director on 06 Nov 2023. Kantilal Mangalchand Hiran was appointed as Director on 05 Sep 2023. Actgen Pharma has 10 board changes on record in total.